Complex Interaction Between Migraine Symptoms and Gastrointestinal Comorbidities
Researchers searched publication databases for studies of the gut-brain connection, migraine, and gastric disorders.
Researchers searched publication databases for studies of the gut-brain connection, migraine, and gastric disorders.
Rimegepant is an oral calcitonin gene-related peptide receptor antagonist.
Atorvastatin may have augmentative effects with sodium valproate in the reduction of migraines with aura.
Researchers presented their study results comparing headache education with mindfulness-based stress reduction for patients with migraine at the AAN 2021 Virtual Annual Meeting,
Paul G. Mathew, MD and Steven D. Bender, DDS, uniquely encounter patients with TMD and migraine in their respective practice and offer their insight regarding the diagnosis and management this often overlooked comorbidity.
Distinct pattern of abnormal brain connection on fMRI can assist in the differentiation between a healthy brain and a brain with migraine without aura.
Ubrogepant, the newly approved calcitonin gene-related peptide antagonist, can relieve migraine symptoms within 2 hours after initial dose.
Researchers found evidence for a divergent association between lifetime MDD and the prevalence and severity of symptoms in patients with migraine.
The authors refute a systematic review and meta-analysis of literature on greater occipital nerve block for the treatment of chronic migraine headaches by Shauly and colleagues and published in Plastic and Reconstructive Surgery, citing extensive limitations and claiming the study ultimately raises more questions than answers.
Biofeedback may effectively improve headache and urinary incontinence related to prostatectomy.